Aydın Eresen

695 total citations
46 papers, 501 citations indexed

About

Aydın Eresen is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering. According to data from OpenAlex, Aydın Eresen has authored 46 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Biomedical Engineering. Recurrent topics in Aydın Eresen's work include Radiomics and Machine Learning in Medical Imaging (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Aydın Eresen is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (12 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Aydın Eresen collaborates with scholars based in United States, China and Qatar. Aydın Eresen's co-authors include Zhuoli Zhang, Vahid Yaghmai, Jia Yang, Junjie Shangguan, Nevrez İmamoğlu, Mehmet Önder Efe, Yury Velichko, Yu Li, Quanhong Ma and Al B. Benson and has published in prestigious journals such as International Journal of Molecular Sciences, Magnetic Resonance in Medicine and Expert Systems with Applications.

In The Last Decade

Aydın Eresen

43 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aydın Eresen United States 14 202 177 129 103 92 46 501
Bin Lan China 12 336 1.7× 56 0.3× 182 1.4× 100 1.0× 438 4.8× 36 1.0k
Lili Wu China 15 150 0.7× 53 0.3× 69 0.5× 220 2.1× 233 2.5× 57 909
Iraj Hosseini United States 11 188 0.9× 105 0.6× 76 0.6× 215 2.1× 174 1.9× 31 519
Xiaozhou Yu China 13 161 0.8× 40 0.2× 26 0.2× 113 1.1× 147 1.6× 42 472
Sandhya Sharma India 12 148 0.7× 23 0.1× 144 1.1× 27 0.3× 153 1.7× 61 585
Huaguang Li China 14 190 0.9× 39 0.2× 66 0.5× 19 0.2× 105 1.1× 48 747
Qian Dong China 13 114 0.6× 45 0.3× 72 0.6× 45 0.4× 121 1.3× 54 512
Simon Chen United States 15 97 0.5× 103 0.6× 20 0.2× 44 0.4× 177 1.9× 28 782
Xiancong Chen China 12 71 0.4× 103 0.6× 24 0.2× 56 0.5× 205 2.2× 27 559

Countries citing papers authored by Aydın Eresen

Since Specialization
Citations

This map shows the geographic impact of Aydın Eresen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aydın Eresen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aydın Eresen more than expected).

Fields of papers citing papers by Aydın Eresen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aydın Eresen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aydın Eresen. The network helps show where Aydın Eresen may publish in the future.

Co-authorship network of co-authors of Aydın Eresen

This figure shows the co-authorship network connecting the top 25 collaborators of Aydın Eresen. A scholar is included among the top collaborators of Aydın Eresen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aydın Eresen. Aydın Eresen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Eresen, Aydın, et al.. (2024). Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. International Journal of Molecular Sciences. 25(22). 12038–12038. 5 indexed citations
3.
Eresen, Aydın, et al.. (2024). Sorafenib plus memory-like natural killer cell immunochemotherapy boosts treatment response in liver cancer. BMC Cancer. 24(1). 1215–1215. 2 indexed citations
4.
Eresen, Aydın, et al.. (2024). MRI radiomics to monitor therapeutic outcome of sorafenib plus IHA transcatheter NK cell combination therapy in hepatocellular carcinoma. Journal of Translational Medicine. 22(1). 7 indexed citations
5.
Eresen, Aydın, et al.. (2024). Self-Guided Algorithm for Fast Image Reconstruction in Photo-Magnetic Imaging: Artificial Intelligence-Assisted Approach. Bioengineering. 11(2). 126–126. 1 indexed citations
6.
Li, Xiao, Lin Lü, Yue Wang, et al.. (2023). Identification of Myocardial Scarring Using Contrast‐Free Cardiac MRI in Patients With Autoimmune Rheumatic Diseases. Journal of Magnetic Resonance Imaging. 60(3). 979–987. 2 indexed citations
7.
Eresen, Aydın, Zhuoli Zhang, & Vahid Yaghmai. (2021). Strategies to improve sorafenib efficacy during image-guided treatment of hepatocellular carcinoma. Annals of Translational Medicine. 9(23). 1745–1745. 6 indexed citations
8.
Eresen, Aydın, Junjie Shangguan, Bin Wang, et al.. (2021). Early Differentiation of Irreversible Electroporation Ablation Regions With Radiomics Features of Conventional MRI. Academic Radiology. 29(9). 1378–1386. 6 indexed citations
9.
Eresen, Aydın, Jia Yang, Alessandro Scotti, et al.. (2021). Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma. Annals of Translational Medicine. 9(13). 1089–1089. 13 indexed citations
10.
Yang, Jia, Aydın Eresen, Junjie Shangguan, et al.. (2021). Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic cancer. OncoImmunology. 10(1). 1875638–1875638. 41 indexed citations
11.
Shangguan, Anna Junjie, Na Shang, Matteo Figini, et al.. (2020). Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Cytotherapy. 22(1). 6–15. 13 indexed citations
12.
Eresen, Aydın, Jia Yang, Junjie Shangguan, et al.. (2020). Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Investigation. Academic Radiology. 28(6). e147–e154. 13 indexed citations
13.
Eresen, Aydın, Jia Yang, Junjie Shangguan, et al.. (2020). MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma. Journal of Translational Medicine. 18(1). 61–61. 21 indexed citations
14.
Shangguan, Anna Junjie, Jia Yang, Aydın Eresen, et al.. (2020). <p>Intraprocedural Transcatheter Intraarterial Perfusion (TRIP)-MRI for Evaluation of Irreversible Electroporation Therapy Response in a Rabbit Liver Tumor Model</p>. Clinical and Experimental Gastroenterology. Volume 13. 543–553. 3 indexed citations
15.
Eresen, Aydın, Yu Li, Jia Yang, et al.. (2020). Preoperative assessment of lymph node metastasis in Colon Cancer patients using machine learning: a pilot study. Cancer Imaging. 20(1). 30–30. 23 indexed citations
16.
Yang, Jia, Junjie Shangguan, Aydın Eresen, et al.. (2019). Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies. Pathology - Research and Practice. 215(12). 152691–152691. 22 indexed citations
17.
Li, Yu, Aydın Eresen, Yun Lu, et al.. (2019). Radiomics signature for the preoperative assessment of stage in advanced colon cancer.. PubMed. 9(7). 1429–1438. 31 indexed citations
18.
Hu, Su, Liang Pan, Junjie Shangguan, et al.. (2018). Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model. Journal of Immunological Methods. 465. 1–6. 5 indexed citations
19.
Eresen, Aydın, Peng Li, & Jim Ji. (2014). Correlating 2D histological slice with 3D MRI image volume using smart phone as an interactive tool for muscle study. PubMed. 25. 6418–6421. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bin Lan Breakdown of academic impact, for papers by Lili Wu Breakdown of academic impact, for papers by Iraj Hosseini Breakdown of academic impact, for papers by Xiaozhou Yu Breakdown of academic impact, for papers by Sandhya Sharma Breakdown of academic impact, for papers by Huaguang Li Breakdown of academic impact, for papers by Qian Dong Breakdown of academic impact, for papers by Simon Chen Breakdown of academic impact, for papers by Xiancong Chen
Rankless by CCL
2026